Pluripotent Stem Cells

Catalogues Pluripotent Stem Cells

MACS® Cytokines: recombinant cytokines & growth factors

At Miltenyi Biotec, high production standards, up to GMP, ensure constant high quality. A broad choice of cytokines for demanding applications make up our portfolio more

News Pluripotent Stem Cells

• Thiazole small molecules spark cell differentiation

  A series of thiazole-containing small molecules has been synthesised and the ability of each analogue to induce differentiation in human pluripotent stem cells has been investigated. Andy Whiting et al state that the molecule with the longest, most bulky hydrophobic side chain was found to possess c more

• Lonza: Contract to generate research grade iPSCs by the National Institutes of Health Center for Regenerative Medicine

  The National Institutes of Health Center for Regenerative Medicine (NIH) has awarded Lonza Walkersville, Inc. a contract to generate induced pluripotent stem cells (iPSCs) for research purposes. By definition, iPSCs have the ability to indefinitely self-renew and become any cell type in the body. Be more

• Learning from the linker

  Mature cells can be reprogrammed to pluripotency and thus regain the ability to divide and differentiate into specialized cell types. Although these so-called induced pluripotent stem cells (iPS cells) represent a milestone in stem cell research, many of the biochemical processes that underlie repro more

Publications Pluripotent Stem Cells

• Connexin 43 is involved in the generation of human-induced pluripotent stem cells

  Although somatic cells can be successfully programmed to create pluripotent stem cells by ectopically expressing defined transcriptional factors, reprogramming efficiency is low and the reprogramming mechanism remains unclear. Previous reports have shown that almost all human connexin (CX) isoforms more

• Three‐dimensional neural differentiation of embryonic stem cells with ACM induction in microfibrous matrices in bioreactors

  The clinical use of pluripotent stem cell (PSC)‐derived neural cells requires an efficient differentiation process for mass production in a bioreactor. Toward this goal, neural differentiation of murine embryonic stem cells (ESCs) in three‐dimensional (3D) polyethylene terephthalate microfibrous m more

• Thiol‐acrylate nanocomposite foams for critical size bone defect repair: A novel biomaterial

  Abstract Bone tissue engineering approaches using polymer/ceramic composites show promise as effective biocompatible, absorbable, and osteoinductive materials. A novel class of in situ polymerizing thiol‐acrylate based copolymers synthesized via an amine‐catalyzed Michael addition was studied fo more

Market studies Pluripotent Stem Cells

• Future Directions in Regenerative Medicine

  Big Pharma has begun investing in regenerative medicine: Genzyme in 2008, Pfizer and Novartis in 2009, and Cephalon in 2010. In 3-5 years, investment will reach a “tipping point”, after which no medical industry players will want to be left behind. This report covers the development of therapies to more

• International Stem Cell Corporation (ISCO) - Financial and Strategic SWOT Analysis Review

  International Stem Cell Corporation (International Stem Cell) is a publicly held biotechnology company. It is focused on developing therapeutic products and research products. The company creates human cells for the treatment corneal disease, diabetes, liver disease, and retinal disease through cel more

Websites Pluripotent Stem Cells